SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?


To: fred woodall who wrote (184)3/17/1998 2:26:00 PM
From: yehuda fruchter  Read Replies (2) | Respond to of 471
 
why take a 2.5 gain when there are prospects for a 20+ gain? The blue cross news is excellent news for CYBX and it removes another uncertainty (i.e. reimbursment issues) for the company. It further helps CYBX penetrate its market and maintain sales momentum. The shorts (some of whom have been frequenting this board) should be covering soon, if not today.